Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel
<p>Abstract</p> <p>Background</p> <p>To determine the incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel.</p> <p>Methods</p> <p>We studied the incidence an...
Main Authors: | Donnez Jacques, Roche Henry, Piette Philippe, Vindevogel Anita, Malingret Nathalie, Dalenc Florence, Berliere Martine, Symann Michel, Kerger Joseph, Machiels Jean-Pascal |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-02-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/8/56 |
Similar Items
-
Correction: Tamoxifen and Ovarian Function.
by: Martine Berliere, et al.
Published: (2013-01-01) -
Tamoxifen and ovarian function.
by: Martine Berliere, et al.
Published: (2013-01-01) -
Prognostic Significance of Adjuvant Chemotherapy Induced Amenorrhea in Luminal A and B Subtypes
by: Çetin Ordu, et al.
Published: (2018-07-01) -
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
by: Wanjing Chen, et al.
Published: (2021-02-01) -
Approach to: Amenorrhea
by: Sophie Baril
Published: (2021-04-01)